Craig Millian

Craig Millian

Chief Executive Officer at HLS THERAPEUTICS INC.

Net worth: 64 616 $ as of 30/03/2024

56 year
Health Technology
Consumer Services

Profile

Craig Millian is currently the Chief Executive Officer & Director at HLS Therapeutics, Inc. Prior to this, he was the Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc. from 2021 to 2023.
He was also the Senior Vice President-Neurology & Immunology at EMD Serono, Inc. from 2016 to 2018.
Before that, he worked as the Vice President-Commercial at Vertex Pharmaceuticals, Inc. Mr. Millian has an undergraduate degree from the University of Pennsylvania and an MBA from New York University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
12/02/2023 900 ( 0.01% ) 35 316 $ 30/03/2024
15/11/2023 10,000 ( 0.03% ) 29 300 $ 30/03/2024

Craig Millian active positions

CompaniesPositionStart
HLS THERAPEUTICS INC. Chief Executive Officer 30/04/2023
All active positions of Craig Millian

Former positions of Craig Millian

CompaniesPositionEnd
CORBUS PHARMACEUTICALS HOLDINGS, INC. Chief Operating Officer 13/04/2023
Corporate Officer/Principal 30/11/2018
VERTEX PHARMACEUTICALS INCORPORATED Corporate Officer/Principal -
See the detail of Craig Millian's experience

Training of Craig Millian

University of Pennsylvania Undergraduate Degree
New York University Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Craig Millian's experience

Connections

65

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
VERTEX PHARMACEUTICALS INCORPORATED

Health Technology

CORBUS PHARMACEUTICALS HOLDINGS, INC.

Health Technology

HLS THERAPEUTICS INC.

Health Technology

Private companies1

Health Technology

See company connections